[Federal Register Volume 64, Number 154 (Wednesday, August 11, 1999)]
[Notices]
[Page 43884]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-20645]
[[Page 43883]]
_______________________________________________________________________
Part VI
Department of Health and Human Services
_______________________________________________________________________
National Institutes of Health
_______________________________________________________________________
Recombinant DNA Advisory Committee and Office of Recombinant DNA
Activities; Notice of Meeting and Proposed Actions Under the NIH
Guidelines; Notice
Federal Register / Vol. 64, No. 154 / Wednesday, August 11, 1999 /
Notices
[[Page 43884]]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Recombinant DNA Advisory Committee; Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given of a meeting
of the Recombinant DNA Advisory Committee on September 2-3, 1999. The
meeting will be held at the National Institutes of Health, Building
31C, 6th Floor, Conference Room 10, 9000 Rockville Pike, Bethesda,
Maryland 20892, starting on September 2, 1999, at approximately 9:00
a.m., and will recess at approximately 5:00 p.m. The meeting will
reconvene on September 3, 1999, at approximately 8:30 a.m. and will
adjourn at approximately 5:00 p.m. The meeting will be held to discuss
Proposed Actions under the NIH Guidelines for Research Involving
Recombinant DNA Molecules (59 FR 34496) and other matters to be
considered by the Committee. The Proposed Actions will follow this
notice of meeting. The meeting will be open to the public. Attendance
by the public will be limited to space available.
Debra W. Knorr, Deputy Director, Office of Recombinant DNA
Activities, National Institutes of Health, MSC 7010, 6000 Executive
Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone (301) 496-
9838, FAX (301) 496-9839, will provide a summary of the meeting and a
roster of committee members upon request. Individuals who plan to
attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should contact Ms.
Knorr in advance of the meeting. The Office of Recombinant DNA
Activities (ORDA) web site is located at http://www.nih.gov/od/orda for
further information about the office.
OMB's ``Mandatory Information Requirements for Federal Assistance
Program Announcements'' (45 FR 39592, June 11, 1980) requires a
statement concerning the official government programs contained in the
Catalog of Federal Domestic Assistance. Normally NIH lists in its
announcements the number and title of affected individual programs for
the guidance of the public. Because the guidance in this notice covers
virtually every NIH and Federal research program in which DNA
recombinant molecule techniques could be used, it has been determined
not to be cost effective or in the public interest to attempt to list
these programs. Such a list would likely require several additional
pages. In addition, NIH could not be certain that every Federal program
would be included as many Federal agencies, as well as private
organizations, both national and international, have elected to follow
the NIH Guidelines. In lieu of the individual program listing, NIH
invites readers to direct questions to the information address above
about whether individual programs listed in the Catalog of Federal
Domestic Assistance are affected.
Dated: July 27, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-20645 Filed 8-10-99; 8:45 am]
BILLING CODE 4140-01-P
